BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients

BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients

Background Current research in breast cancer focuses on individualization of local and systemic therapies with adequate escalation or de-escalation strategies. As a result, about two-thirds of breast cancer patients can be cured, but up to one-third eventually develop metastatic disease, which is co...

Full description

Bibliographic Details
Main Authors: Manfred Wischnewsky, Lukas Schwentner, Joachim Diessner, Amelie de Gregorio, Ralf Joukhadar, Dayan Davut, Jessica Salmen, Inga Bekes, Matthias Kiesel, Max Müller-Reiter, Maria Blettner, Regine Wolters, Wolfgang Janni, Rolf Kreienberg, Achim Wöckel, Florian Ebner
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
breast cancer
risk
prediction
BRENDA
score
follow up
Online Access:https://www.mdpi.com/2072-6694/13/13/3121

Internet

https://www.mdpi.com/2072-6694/13/13/3121

Similar Items